PeopleBeatingCancer

Our Mission

PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.

Click the orange button to the right to learn more.

Learn More

Keytruda® (Pembrolizumab) for Cancer: What Patients Need to Know

Share Button

Keytruda® (Pembrolizumab) for Cancer: What Patients Need to Know. A Complete Guide to Benefits, Side Effects, Integrative Therapies, and Recovery.

Keytruda (generic name: pembrolizumab) is one of the most important advances in cancer treatment over the past decade. Unlike chemotherapy, which directly kills rapidly dividing cells, Keytruda helps your own immune system recognize and attack cancer.

For many patients with melanoma, lung cancer, kidney cancer, bladder cancer, head and neck cancer, triple-negative breast cancer, Hodgkin lymphoma, MSI-high colorectal cancer, and dozens of other cancers, Keytruda has produced long-lasting remissions that were rarely seen before immunotherapy.

The challenge is that stimulating the immune system can also cause it to attack healthy organs, leading to unique immune-related side effects that differ from chemotherapy.

The good news is that many patients tolerate Keytruda well, and growing evidence suggests that nutrition, exercise, sleep, stress reduction, vitamin D optimization, and management of inflammation may improve quality of life during treatment.

I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage cancer is to combine the best of conventional and evidence-based non-conventional therapies.

I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.

Before beginning Keytruda for cancer, consider:

Scroll down the page and post a question or a comment if there’s anything you’d like to know about carboplatin + paclitaxel for cancer.

Good luck,

David Emerson

Concepts Central to Managing Your Cancer-

What is Keytruda?

Drug Generic Name Drug Class
Keytruda Pembrolizumab PD-1 Immune Checkpoint Inhibitor

Instead of poisoning cancer cells, Keytruda blocks the PD-1 checkpoint on T-cells.

Normally:

Cancer → activates PD-L1 → turns off T-cells

Keytruda blocks PD-1:

Cancer → T-cells stay activated → immune system attacks tumor

Because the immune system is doing the work, responses can continue months or even years after treatment ends in some patients.

Which Cancers Is Keytruda Used To Treat?

Keytruda is FDA-approved for many cancers, including:

  • Melanoma
  • Non-small cell lung cancer (NSCLC)
  • Triple-negative breast cancer
  • Kidney cancer
  • Bladder cancer
  • Head and neck cancers
  • Classical Hodgkin lymphoma
  • Esophageal cancer
  • Gastric cancer
  • Cervical cancer
  • Endometrial cancer
  • MSI-high colorectal cancer
  • Liver cancer
  • Merkel cell carcinoma
  • Cutaneous squamous cell carcinoma
  • Many tissue-agnostic MSI-high or TMB-high cancers

New indications continue to be added.

Keytruda® (Pembrolizumab) for Cancer

How Effective Is Keytruda?

Success depends heavily on:

  • Cancer type
  • Disease stage
  • PD-L1 expression
  • MSI status
  • Tumor mutation burden
  • Combination with chemotherapy or targeted therapy

Patients with:

  • High PD-L1
  • MSI-high tumors
  • High mutation burden

often experience the greatest benefit.

Some patients remain cancer-free years after treatment.

Keytruda® (Pembrolizumab) for Cancer

Common Side Effects

Unlike chemotherapy, Keytruda side effects result from an overactive immune system.

Side Effect Frequency
Fatigue ★★★★★
Rash ★★★★☆
Itching ★★★★☆
Joint pain ★★★★☆
Diarrhea ★★★☆☆
Nausea ★★★☆☆
Loss of appetite ★★★☆☆
Thyroid dysfunction ★★★☆☆
Cough ★★★☆☆

Keytruda® (Pembrolizumab) for Cancer

Serious Immune-Related Side Effects

Although uncommon, these require prompt medical evaluation.

Organ Possible Toxicity
Colon Colitis
Lungs Pneumonitis
Liver Hepatitis
Thyroid Hypothyroidism / Hyperthyroidism
Pituitary Hypophysitis
Adrenal glands Adrenal insufficiency
Kidneys Nephritis
Heart Myocarditis
Skin Severe autoimmune reactions
Nervous system Neuropathy, encephalitis (rare)

Early recognition dramatically improves outcomes.

Integrative Therapies With Evidence

Unlike many supplement websites, PeopleBeatingCancer only recommends therapies supported by published research.

1. Exercise ★★★★★

Strong evidence shows exercise reduces:

  • Fatigue
  • Physical decline
  • Depression
  • Anxiety
  • Loss of muscle
  • Goal:

150 minutes/week

Research consistently shows exercise is safe during immunotherapy unless restricted by your oncology team.

Keytruda® (Pembrolizumab) for Cancer

2. Mediterranean Diet ★★★★★

The Mediterranean diet supports:

  • Healthy gut microbiome
  • Lower inflammation
  • Better cardiovascular health
  • Better immune function

Some observational studies suggest healthier dietary patterns may be associated with improved immunotherapy outcomes, although this has not been proven in randomized trials.

3. Adequate Protein ★★★★★

Cancer patients often need:

1.2–1.5 g protein/kg/day

Adequate protein supports:

  • Muscle preservation
  • Immune function
  • Recovery
  • Physical activity

4. Vitamin D Optimization ★★★★☆

Vitamin D deficiency is common among cancer patients.

Adequate levels are associated with:

  • Improved immune regulation
  • Better bone health
  • Reduced falls
  • Possible improved immunotherapy response (ongoing research)

Testing before supplementing is recommended.

5. Sleep Optimization ★★★★★

Sleep affects:

  • Immune function
  • Recovery
  • Fatigue
  • Cognitive function

Strategies include:

  • Consistent sleep schedule
  • Morning sunlight
  • Reduced evening screen exposure
  • Cognitive behavioral therapy for insomnia (CBT-I)

6. Mindfulness / Meditation ★★★★☆

Clinical trials show benefits for:

  • Anxiety
  • Depression
  • Sleep quality
  • Stress reduction

These interventions improve quality of life, though they are not cancer treatments.

7. Gut Microbiome Support ★★★★☆

Emerging evidence suggests that a diverse gut microbiome may influence responses to PD-1 inhibitors.

Potential strategies include:

  • High-fiber foods
  • Fruits and vegetables
  • Fermented foods (if appropriate)
  • Avoiding unnecessary antibiotics

Routine probiotic supplements during immunotherapy remain controversial, and some studies suggest they could reduce microbiome diversity. Discuss their use with your oncology team.

Supplements Requiring Caution

Many patients ask whether supplements will interfere with immunotherapy.

Current evidence suggests caution with:

  • High-dose antioxidant supplements during active treatment
  • High-dose vitamin E
  • High-dose beta-carotene
  • Multiple unproven immune stimulants
  • Large numbers of supplements taken simultaneously

Always discuss supplements with your oncologist, particularly because some may alter immune activity or interact with other medications.

Monitoring During Treatment

Patients receiving Keytruda typically undergo:

  • CBC
  • Comprehensive metabolic panel
  • Thyroid function tests
  • Liver enzymes
  • Kidney function
  • Assessment for new cough, diarrhea, rash, or shortness of breath
  • Monitoring for endocrine symptoms (fatigue, dizziness, headaches)

Any new or worsening symptoms should be reported promptly, as early treatment of immune-related adverse events often prevents more serious complications.

Questions to Ask Your Oncologist

  • Is my tumor PD-L1 positive?
  • Should my tumor be tested for MSI or tumor mutation burden?
  • How long will I receive Keytruda?
  • What symptoms require an immediate call?
  • What laboratory tests will be monitored?
  • Should I avoid any supplements?
  • Should I receive vaccinations during treatment?
  • How can I reduce fatigue?
  • When should corticosteroids be used if immune-related side effects occur?

PeopleBeatingCancer Evidence Rating

Therapy Evidence Recommendation
Exercise ★★★★★ Strongly Recommended
Mediterranean Diet ★★★★★ Strongly Recommended
Adequate Protein Intake ★★★★★ Strongly Recommended
Sleep Optimization ★★★★★ Strongly Recommended
Vitamin D (if deficient) ★★★★☆ Recommended with testing
Mindfulness / Meditation ★★★★☆ Recommended for symptom management
High-Fiber Diet / Gut Microbiome Support ★★★★☆ Promising; food-first approach
Routine Probiotic Supplements ★★☆☆☆ Mixed evidence; discuss with your oncology team
High-Dose Antioxidant Supplements During Treatment ★☆☆☆☆ Generally Not Recommended

Key Takeaways

  • Keytruda is an immune checkpoint inhibitor that works by reactivating the immune system rather than directly killing cancer cells.
  • It has transformed the treatment of many advanced cancers and can produce durable remissions in selected patients.
  • Immune-related side effects differ from chemotherapy and can affect almost any organ, making early recognition essential.
  • Regular monitoring and prompt reporting of new symptoms are critical for safe treatment.
  • Exercise, a Mediterranean diet, adequate protein, sleep optimization, vitamin D repletion when needed, and stress reduction have the strongest evidence for supporting overall health and quality of life during treatment.
  • Integrative therapies should complement—not replace—evidence-based cancer care.

To learn more:

To prepare for Keytruda–

Keytruda- Induced side effects-

Lifestyle Post Therapy

Key Research References

Mechanism and Clinical Evidence

Management of Immune-Related Adverse Events

Exercise and Lifestyle

Gut Microbiome and Immunotherapy

Leave a Comment:

Popular posts

Multiple Myeloma Diet
 Multiple Myeloma Multiple Myeloma Diet
Feb 15, 2022
Multiple Myeloma Second Opinion: 7 Questions Every Newly Diagnosed Patient Should Ask
 Multiple Myeloma
Nov 04, 2022
C-B-D Enhances Velcade (BORT)
 integrative therapy Multiple Myeloma
Aug 07, 2022
Can Endometrial Polyps Become Cancer? What Women Need to Know
 Endometrial Cancer
Nov 14, 2021